PF
TEVA icon

Phoenix Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Phoenix Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,202,500
Closed -$18.5K – 449
2025
Q1 		$18.5K Buy
1,202,500
+462,500
+63% +$8.26M ﹤0.01% 368
2024
Q4 		$16.3K Buy
+740,000
New +$13.5M ﹤0.01% 356
2024
Q2 		– Sell
-370,000
Closed -$5.22K – 434
2024
Q1 		$5.22K Buy
+370,000
New +$4.66M ﹤0.01% 411
2022
Q3 		– Sell
-100,000
Closed -$752K – 371
2022
Q2 		$752K Buy
+100,000
New +$871K 0.02% 254

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Phoenix Financial's TEVA Position: Q2 2026 in Review

Phoenix Financial increased its Teva Pharmaceuticals (TEVA) stake by 0.36% in Q2 2026, buying an estimated $5.19M and bringing the position to 42,933,367 shares worth $1.45B. The position accounts for 9.94% of the portfolio, ranked #1.

Phoenix Financial first reported a position in TEVA in Q3 2019 and has held it in 28 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Phoenix Financial held 42,933,367 shares of Teva Pharmaceuticals worth $1.45B as of Q2 2026.
  • Phoenix Financial bought 155,953 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.19M.
  • Teva Pharmaceuticals made up 9.94% of Phoenix Financial's portfolio in Q2 2026, its #1 holding.
  • Phoenix Financial first reported a position in Teva Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.